Analytical Data
-
Gene name
SAS
- Application
-
Alternative Names
Tetraspanin-31. Tspan-31. Sarcoma-amplified sequence
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q12999
-
Expression Region
1-210 aa
-
AA Sequence
MVCGGFACSKNALCALNVVYMLVSLLLIGVAAWGKGLGLVSSIHIIGGVIAVGVFLLLIAVAGLVGAVNHHQVLLFFYMIILGLVFIFQFVISCSCLAINRSKQTDVINASWWVMSNKTRDELERSFDCCGLFNLTTLYQQDYDFCTAICKSQSPTCQMCGEKFLKHSDEALKILGGVGLFFSFTEILGVWLAMRFRNQKDPRANPSAFL
-
Molecular Weight
48.84 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAS (Streptomyces albulus serine racemase) recombinant protein research has garnered significant attention due to its potential applications in various fields, including biotechnology, pharmaceuticals, and molecular biology. Serine racemases are enzymes responsible for catalyzing the interconversion between L-serine and D-serine, which play crucial roles in neurological processes and metabolic pathways. The increased understanding of D-serine's role as a neurotransmitter and its implications for neurological disorders, such as schizophrenia and neurodegenerative diseases, has spurred interest in studying this enzyme. By engineering SAS recombinant proteins, researchers aim to elucidate the enzyme's structure-function relationships, enhance its activity, and optimize its stability for industrial applications. Furthermore, SAS-derived proteins may contribute to the development of novel therapeutic strategies targeting neurotransmission and metabolic regulation. As a result, the study of SAS recombinant proteins not only advances our knowledge of amino acid metabolism but also holds promise for innovative treatments in neuroscience and related disciplines.
